Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doriano Fabbro

Showing results (31-40 of 121) with videos related to

Pageof 13
Sort By:
Journal of Medicinal Chemistry|May 24, 2022
The Dawn of Allosteric BCR-ABL1 Drugs: From a Phenotypic Screening Hit to an Approved DrugMingxing Teng, Marlise R Luskin, Sandra W Cowan-Jacob, et al.
European Journal of Medicinal Chemistry|March 4, 2008
Synthesis and biological evaluation of diversely substituted indolin-2-onesFadoua Bouchikhi, Emilie Rossignol, Martine Sancelme, et al.
Journal of Neurochemistry|October 17, 2019
Synergistic growth inhibition mediated by dual PI3K/mTOR pathway targeting and genetic or direct pharmacological AKT inhibition in human glioblastoma modelsCaroline von Achenbach, Michael Weller, Kerstin Kaulich, et al.
Structure (London, England : 1993)|June 9, 2005
The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activationSandra W Cowan-Jacob, Gabriele Fendrich, Paul W Manley, et al.
Bioorganic & Medicinal Chemistry Letters|October 19, 2011
Substrate profiling of IGF-1R and InsR: identification of a potent pentamer substrateJulien Chapelat, Frédéric Berst, Andreas L Marzinzik, et al.
European Journal of Medicinal Chemistry|October 9, 2012
The Substrate-Activity-Screening methodology applied to receptor tyrosine kinases: a proof-of-concept studyJulien Chapelat, Frédéric Berst, Andreas L Marzinzik, et al.
Journal of Natural Products|May 24, 2003
New sesquiterpene quinols from a Micronesian sponge, Aka spVenugopal J R V Mukku, Ru A Edrada, Francis J Schmitz, et al.
Blood|March 26, 2005
Activation mutations of human c-KIT resistant to imatinib mesylate are sensitive to the tyrosine kinase inhibitor PKC412Joseph D Growney, Jennifer J Clark, Jennifer Adelsperger, et al.
British Journal of Pharmacology|August 20, 2014
The ceramide kinase inhibitor NVP-231 inhibits breast and lung cancer cell proliferation by inducing M phase arrest and subsequent cell deathOleksandr Pastukhov, Stephanie Schwalm, Uwe Zangemeister-Wittke, et al.
Cancer Cell|July 19, 2002
Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412Ellen Weisberg, Christina Boulton, Louise M Kelly, et al.
Pageof 13

Showing results (31-40 of 121) with videos related to

Sort By:
Pageof 13
Journal of Medicinal Chemistry|May 24, 2022
The Dawn of Allosteric BCR-ABL1 Drugs: From a Phenotypic Screening Hit to an Approved DrugMingxing Teng, Marlise R Luskin, Sandra W Cowan-Jacob, et al.
European Journal of Medicinal Chemistry|March 4, 2008
Synthesis and biological evaluation of diversely substituted indolin-2-onesFadoua Bouchikhi, Emilie Rossignol, Martine Sancelme, et al.
Journal of Neurochemistry|October 17, 2019
Synergistic growth inhibition mediated by dual PI3K/mTOR pathway targeting and genetic or direct pharmacological AKT inhibition in human glioblastoma modelsCaroline von Achenbach, Michael Weller, Kerstin Kaulich, et al.
Structure (London, England : 1993)|June 9, 2005
The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activationSandra W Cowan-Jacob, Gabriele Fendrich, Paul W Manley, et al.
Bioorganic & Medicinal Chemistry Letters|October 19, 2011
Substrate profiling of IGF-1R and InsR: identification of a potent pentamer substrateJulien Chapelat, Frédéric Berst, Andreas L Marzinzik, et al.
European Journal of Medicinal Chemistry|October 9, 2012
The Substrate-Activity-Screening methodology applied to receptor tyrosine kinases: a proof-of-concept studyJulien Chapelat, Frédéric Berst, Andreas L Marzinzik, et al.
Journal of Natural Products|May 24, 2003
New sesquiterpene quinols from a Micronesian sponge, Aka spVenugopal J R V Mukku, Ru A Edrada, Francis J Schmitz, et al.
Blood|March 26, 2005
Activation mutations of human c-KIT resistant to imatinib mesylate are sensitive to the tyrosine kinase inhibitor PKC412Joseph D Growney, Jennifer J Clark, Jennifer Adelsperger, et al.
British Journal of Pharmacology|August 20, 2014
The ceramide kinase inhibitor NVP-231 inhibits breast and lung cancer cell proliferation by inducing M phase arrest and subsequent cell deathOleksandr Pastukhov, Stephanie Schwalm, Uwe Zangemeister-Wittke, et al.
Cancer Cell|July 19, 2002
Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412Ellen Weisberg, Christina Boulton, Louise M Kelly, et al.
Pageof 13